Skip to main content
SpringerLink
Log in

Everolimus-eluting stents were found to have superior safety and efficacy

  • Clinical study
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. Claessen BE, Stone GW, Smits PC, Kedhi E, Kikkert WJ, Piek JJ, Henriques JPS.Safety and Efficacy of Everolimus-Eluting Stents Compared to Paclitaxel-Eluting Stents: A Meta-Analysis of 4 Trials. 22nd Annual Scientific Symposium on Transcatheter Cardiovascular Therapeutics: abstr. 276, 21 Sep 2010. Available from: URL: http://www.tctconference.com

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Everolimus-eluting stents were found to have superior safety and efficacy. React. Wkly. 1323, 2 (2010). https://doi.org/10.2165/00128415-201013230-00003

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128415-201013230-00003

Keywords

Search

Navigation